Literature DB >> 11726418

The predictive value of ventricular fibrillation electrocardiogram signal frequency and amplitude variables in patients with out-of-hospital cardiac arrest.

H U Strohmenger1, T Eftestol, K Sunde, V Wenzel, M Mair, H Ulmer, K H Lindner, P A Steen.   

Abstract

UNLABELLED: We evaluated ventricular fibrillation frequency and amplitude variables to predict successful countershock, defined as pulse-generating electrical activity. We also elucidated whether bystander cardiopulmonary resuscitation (CPR) influences these electrocardiogram (ECG) variables. In 89 patients with out-of-hospital cardiac arrest, ECG recordings of 594 countershock attempts were collected and analyzed retrospectively. By using fast Fourier transformation analysis of the ventricular fibrillation ECG signal in the frequency range 0.333-15 Hz (median [range]), median frequency, dominant frequency, spectral edge frequency, and amplitude were as follows: 4.4 (2.4-7.5) Hz, 4.0 (0.7-7.0) Hz, 7.7 (3.7-13.7) Hz, and 0.94 (0.24-1.95) mV, respectively, before successful countershock (n = 59). These values were 3.8 (0.8-7.7) Hz (P = 0.0002), 3.0 (0.3-9.7) Hz (P < 0.0001), 7.3 (2.0-14.0) Hz (P < 0.05), and 0.53 (0.03-3.03) mV (P < 0.0001), respectively, before unsuccessful countershock (n = 535). In patients in whom bystander CPR was performed (n = 51), ventricular fibrillation frequency and amplitude before the first defibrillation attempt were higher than in patients without bystander CPR (n = 38) (median frequency, 4.4 [2.4-7.5] vs 3.7 [1.8-5.3] Hz, P < 0.0001; dominant frequency, 3.8 [0.9-7.7] vs 2.6 [0.8-5.9] Hz, P < 0.0001; spectral edge frequency, 8.4 [4.8-12.9] vs 7.2 [3.9-12.1] Hz, P < 0.05; amplitude, 0.79 [0.06-4.72] vs 0.67 [0.16-2.29] mV, P = 0.0647). Receiver operating characteristic curves demonstrate that successful countershocks will be best discriminated from unsuccessful countershocks by ventricular fibrillation amplitude (3000-ms epoch). At 73% sensitivity, a specificity of 67% was obtained with this variable. IMPLICATIONS: In patients with out-of-hospital cardiac arrest, successful countershocks will be best discriminated from unsuccessful countershocks by ventricular fibrillation amplitude (3000-ms epoch). At 73% sensitivity, a specificity of 67% was obtained with this variable.

Entities:  

Mesh:

Year:  2001        PMID: 11726418     DOI: 10.1097/00000539-200112000-00016

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  5 in total

1.  Insights Into the Spatiotemporal Patterns of Complexity of Ventricular Fibrillation by Multilead Analysis of Body Surface Potential Maps.

Authors:  Marianna Meo; Arnaud Denis; Frédéric Sacher; Josselin Duchâteau; Ghassen Cheniti; Stéphane Puyo; Laura Bear; Pierre Jaïs; Mélèze Hocini; Michel Haïssaguerre; Olivier Bernus; Rémi Dubois
Journal:  Front Physiol       Date:  2020-09-23       Impact factor: 4.566

2.  Logarithm of the absolute correlations of the ECG waveform estimates duration of ventricular fibrillation and predicts successful defibrillation.

Authors:  Lawrence D Sherman; Thomas D Rea; James D Waters; James J Menegazzi; Clifton W Callaway
Journal:  Resuscitation       Date:  2008-07-01       Impact factor: 5.262

3.  Preshock cardiopulmonary resuscitation worsens outcome from circulatory phase ventricular fibrillation with acute coronary artery obstruction in swine.

Authors:  Julia H Indik; Ronald W Hilwig; Mathias Zuercher; Karl B Kern; Marc D Berg; Robert A Berg
Journal:  Circ Arrhythm Electrophysiol       Date:  2009-02-18

4.  Amplitude Changes during Ventricular Fibrillation: A Mechanistic Insight.

Authors:  Jane C Caldwell; Francis L Burton; Stuart M Cobbe; Godfrey L Smith
Journal:  Front Physiol       Date:  2012-05-23       Impact factor: 4.566

Review 5.  [Adult advanced life support].

Authors:  Jasmeet Soar; Bernd W Böttiger; Pierre Carli; Keith Couper; Charles D Deakin; Therese Djärv; Carsten Lott; Theresa Olasveengen; Peter Paal; Tommaso Pellis; Gavin D Perkins; Claudio Sandroni; Jerry P Nolan
Journal:  Notf Rett Med       Date:  2021-06-08       Impact factor: 0.826

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.